Subutex 300 mg, Depot-Injektionslösung - Swissmedic Key 68561002 Registration Holder Indivior Schweiz AG Name Subutex 300 mg, Depot-Injektionslösung Date of registration 02.06.2022 Introduction of Sequence 02.06.2022 ATC-Classification Buprenorphine (N07BC01) Revision date WHO WHO-DDD Valid until 01.06.2027 Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 01.01.30. Description Swissmedic categorie. A+ SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680685610027 Medication Code Synthetika Pharmacode Disponibility
Composition buprenorphinum 300 mg, poly(lactidum-co-glycolidum) 50/50 (0.17 - 0.22 dl/g), N-methylpyrrolidonum, ad solutionem pro 1.5 ml. Packungsbestandteile Galenic Form Depot-Injektionslösung Excipiens Active Agent Dose Buprenorphine 300mg / 1.5ml
Inactive agents N-Methylpyrrolidonum Poly(Lactidum-Co-Glycolidum) 50/50 (0.17-0.22 Dl/g)
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
